U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Oculopharyngeal muscular dystrophy 1(OPMD1)

MedGen UID:
1054618
Concept ID:
CN376802
Disease or Syndrome
Synonym: OPMD1
 
Gene (location): PABPN1 (14q11.2)
 
Monarch Initiative: MONDO:0958176
OMIM®: 164300

Disease characteristics

Excerpted from the GeneReview: Oculopharyngeal Muscular Dystrophy
Oculopharyngeal muscular dystrophy (OPMD) is characterized by ptosis and dysphagia due to selective involvement of the muscles of the eyelids and pharynx, respectively. For the vast majority of individuals with typical OPMD, the mean age of onset of ptosis is usually 48 years and of dysphagia 50 years; in 5%-10% of individuals with severe OPMD, onset of ptosis and dysphagia occur before age 45 years and is associated with lower limb girdle weakness starting around age 60 years. Swallowing difficulties, which determine prognosis, increase the risk for potentially life-threatening aspiration pneumonia and poor nutrition. Other manifestations as the disease progresses can include limitation of upward gaze, tongue atrophy and weakness, chewing difficulties, wet voice, facial muscle weakness, axial muscle weakness, and proximal limb girdle weakness predominantly in lower limbs. Some individuals with severe involvement will eventually need a wheelchair. Neuropsychological tests have shown altered scores in executive functions in some. [from GeneReviews]
Authors:
Capucine Trollet  |  Alexis Boulinguiez  |  Fanny Roth, et. al.   view full author information

Additional description

From OMIM
Oculopharyngeal muscular dystrophy-1 (OPMD1) is an autosomal dominant late-onset neuromuscular disease characterized by proximal muscle weakness, ptosis, and swallowing difficulty (summary by Robinson et al., 2006). Genetic Heterogeneity of Oculopharyngeal Muscular Dystrophy See also OPMD2 (620460), caused by mutation in the HNRNPA2B1 gene (600124) on chromosome 7p15.  http://www.omim.org/entry/164300

Professional guidelines

PubMed

Keene KR, Kan HE, van der Meeren S, Verbist BM, Tannemaat MR, Beenakker JM, Verschuuren JJGM
J Cachexia Sarcopenia Muscle 2022 Dec;13(6):2820-2834. Epub 2022 Sep 29 doi: 10.1002/jcsm.13089. PMID: 36172973Free PMC Article
Avdagic E, Phelps PO
Dis Mon 2020 Oct;66(10):101040. Epub 2020 Jun 27 doi: 10.1016/j.disamonth.2020.101040. PMID: 32605719
Mensah A, Witting N, Duno M, Milea D, Vissing J
Acta Ophthalmol 2014 May;92(3):e247-9. Epub 2013 Jul 15 doi: 10.1111/aos.12243. PMID: 23848287

Recent clinical studies

Diagnosis

Lee CC, Huang CC, Chen SS
Zhonghua Yi Xue Za Zhi (Taipei) 1995 Dec;56(6):386-92. PMID: 8851479

Clinical prediction guides

Lee CC, Huang CC, Chen SS
Zhonghua Yi Xue Za Zhi (Taipei) 1995 Dec;56(6):386-92. PMID: 8851479

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...